Beta Bionics, Inc. (NASDAQ:BBNX) filed a Form 8-K with the Securities and Exchange Commission on January 30, 2026, disclosing a material event.
Beta Bionics, Inc.'s stock currently trades at $13.83 with a market capitalization of $1.3B. The Healthcare company's stock moved following the disclosure.
